20
Views
4
CrossRef citations to date
0
Altmetric
Research Article

In vivo perivascular implantation of encapsulated packaging cells for prolonged retroviral gene transfer

Pages 491-506 | Published online: 29 Sep 2008

References

  • AEBISC HER, P., TRESCO, P. A., WINN, S. R., GREENE, L. A., and JAEGER, C. B., 1991, Long-term cross-species brain transplantation of a polymer-encapsulated dopamine-secreting cell line. Experimental Neurology, 111, 269–275.
  • CEPKO, C. L., 1989, Immortalization of neural cells via retrovirus-mediated oncogene transduction. Annual Review Neuroscience, 12, 47–65.
  • CULVER, K. W., RAM, Z., WALL BRIDGE, S., ISHII, H., OLDFIELD, E. H., and BLAESE, R. M., 1992, In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science, 256, 1550–1552.
  • DAUTZENBERG, H., SCHULD, U., MULLER, P., LOHR, M., PELEGRIN, M., PIECHACZYK, M., Romus, K., GUNZBURG, W. H., SALMONS, B., and SALLER, R. M., 1999, Development of cellulose sulfate-based polyelectrolyte complex microcapsules for medical applications. Annals of New York Academy of Science, 875, 46–63.
  • FORRESTER, J. S., FISHBEIN, M., HELFANT, R., and FAGIN, J., 1991, A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. Journal of American College of Cardiology, 17, 758–769.
  • FRIEDRICH, G., and SORIANO, P., 1991, Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Genes Development, 5, 1513–1523.
  • HANSSON, G. K., 1997, Cell-mediated immunity in atherosclerosis. Current Opinion in Lipidology, 8, 301–311.
  • HUEHNS, T. Y., KRAUSZ, E., MROCHEN, S., SCHMID, M., ENGELMANN, M. G., ES IN, S., SCHRITTENLOHER, P.-K., HOFLING, B., GUNZBURG, W. H., and NiKoL, S., 1999, Neointimal growth can be influenced by local advential gene delivery via a needle injection catheter. Athersclerosis, 144, 135–150.
  • HUGHES, M., VASSILAKOS, A., ANDREWS, D. W., HORTELANO, G., BELMONT, J. W., and CHANG, P. L., 1994, Delivery of a secretable adenosine deaminase through microcapsules—a novel approach to somatic gene therapy. Human Gene Therapy, 5, 1445–1455.
  • JANKA, I., GUNZBURG, W. H., BREM, G., ERFLE, V., and SALMONS, B., 1993, Retrovirus-receptor interaction is not required for subsequent events in the establishment of infection. Biochemical and Molecular Biology International, 31, 349–357.
  • MAILL ARD, L., and WALSH, K., 1996, Growth-arrest homeobox gene Gax: a molecular strategy to prevent arterial restenosis. Schweizerische Medizinische Wochenschrift, 126, 1721–1726.
  • MILLER, A. D., and BU TT IMORE, C., 1986, Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Molecular Cell Biology, 6, 2895–2902.
  • MORGAN, R. A., and ANDERSON, W. F., 1993, Human gene therapy. Annual Review of Biochemistry, 62, 191–217.
  • MULLER, D. W., 1997, The role of proto-oncogenes in coronary restenosis. Progress in Cardiovascular Disorders, 40, 117–128.
  • S HUEHNS, T. Y., and HOFLING, B., 1996, Molecular biology and post angioplasty restenosis. Atherosclerosis, 123, 17–31.
  • NIKOL, S HUEHNS, T. Y., KRAUSZ, E., ARMEANU S ENGELMANN, M. G., WINDER, D., SALMONS, B., and HOFL ING, B., 1999, Needle injection catheter delivery of the gene for an antibacterial agent inhibits neointimal formation. Gene Therapy, 6, 737–748.
  • OHNO, T., GORDON, D., SAN, H., POMPILL V. J., I MPERIALE, M. J., NABEL, G. J., and NABEL, E. G., 1994, Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science, 265, 781–784.
  • PELEGRIN, M., MARIN, M., NOEL, D., DEL RIO, M., SALLER, R., ST ANGE, J., MITZNER, S., GUNZBURG, W. H., and PIECHACZYK, M., 1998, Systemic long-term delivery of antibodies in immunocompetent animals using cellulose sulphate capsules containing antibody-producing cells. Gene Therapy, 5, 828–834.
  • PRICE, J., TURNER, D., and CEPKO, C., 1987, Lineage analysis in the vertebrate nervous system by retrovirus -mediated gene transfer. Proceedings of the National Academy of Science (USA), 84, 156–160.
  • SALMONS, B., and GUNZBURG, W. H., 1993, Targeting of retroviral vectors for gene therapy. Human Gene Therapy, 4, 129–141.
  • S CHWARTZ, R. S ., HOLMES, D. R., JR., and TOPOL, E. J., 1992, The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. Journal of American College of Cardiology, 20, 1284–1293.
  • SERRUYS, P. W., EMANUELSSON, H., VAN D. G. W ., LUNN, A. C., KIEMENEY, F., MACAYA, C., RUTSCH, W., VIEYNDRICIOC, G., SURYAPRANAT A, H., LEGRAND, V., GOY, J. J., MATERNE, P., BONNIER, H., MORICE, M. C., FAJADET, J., BELARDI, J., COLOMBO, A., GARCIA, E., RUYGROK, P., DE, J. P., and MOREL, M. A., 1996, Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot Study. Circulation, 93, 412–422.
  • S IMONS, M., EDELMAN, E. R., DEKEYSER, J. L., LANGER, R., and ROSENBERG, R. D., 1992, Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature, 359, 67–70.
  • S TANGE, J., MITZNER, S., DAUTZENBERG, H., RAMLOW, W., KNIPPEL, M., STEINER, M., ERNST, B., SCHMIDT, R., and KLINKMANN, H., 1993, Prolonged biochemical and morphological stability of encapsulated liver cells—a new method. Biomaterials and Artificial Cells Immobilization Biotechnology, 21, 343–352.
  • TAI, I. T., and SUN, A. M., 1993, Microencapsulation of recombinant cells: a new delivery system for gene therapy. FASEB Journal, 7, 1061–1069.
  • VERSACI, F., GASPARD ONE, A., TOMAL F., CREA, F., CHIARIELLO, L., and GIOFFRE, P. A., 1997, A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery. New England Journal of Medicine, 336, 817–822.
  • WILEY, J., 1999, http://www.wiley.co.uk/genetherapy, visited September 1999.
  • WINN, S. R., HAM MANG, J. P., EMERICH, D. F., LEE, A., PALMITER, R. D., and BAETGE, E. E., 1994, Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons. Proceedings of the National Academy of Science (USA), 91, 2324–2328.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.